Background: An estimated 31% of HIV-infected (HIV+) individuals in the United States are aged 50 or older. These individuals are at heightened risk of functional decline due to physiological mechanisms that contribute to increased inflammation and alterations in body composition even after effective antiretroviral treatment. Over time, this may contribute to persistently elevated metabolic rate and decreased availability of energy for daily physical activities, as a greater proportion of energy is needed to combat comorbid conditions and repair cellular damage. Recent evidence indicates that in the older, less resilient population, this may accelerate the onset of frailty, disability, and death. Methods To assess and quantify the accelerated onset and temporal dynamics of functional decline in the aging HIV-infected population, we propose to assess gait speed, resting metabolic rate, walking energy expenditure, and objectively measured physical activity in virologically suppressed HIV+ and HIV- men in the Baltimore Multicenter AIDS Cohort Study (MACS). We hypothesize that: (i) gait speed will be slower in HIV+ men and will decrease faster with age relative to HIV- men, (ii) energy expenditure at rest and during standard walking (O2 consumption and CO2 production) will both be elevated in HIV+ men relative to HIV- men, (iii) the association between higher energy expenditure and slower gait speed will be mediated by higher levels of inflammatory markers (e.g., IL-6) and lower lean mass, (iv) HIV+ men will exhibit lower cumulative daily physical activity with more pronounced evidence of fatigue-driven activity patterns than HIV- men, and (v) HIV+ men will have lower day-to-day variability and complexity of circadian rhythms of activity relative to HIV- men. Output: The data obtained from this research will provide critical insight into (i) the amount of excess energy needed for independent living in those with treated HIV infection, and (ii) the associated threats to physical activity an functional mobility. We will use these data as the basis for a future R01 submission designed to: (i) longitudinally evaluate energy expenditure at rest and during walking as causal biomarkers of functional health status and (ii) provide evidence for interventions aimed at: (a) increasing walking efficiency by lowering energy costs through rehabilitative therapy to improve body composition and/or altered drug regimens to lower inflammation, and (b) increasing physical activity and reducing fatigue by targeting low-points of daily activity through analysis of circadin activity patterns. This will contribute to improved function and reduced risk of frailty, disabilit, and death in aging HIV populations.

Public Health Relevance

The lifespan of persons infected with HIV has been considerably extended, but the anticipated long-term health and quality of life for these persons remains unknown. This proposal will evaluate and quantify measures of mobility, functional capacity, and physical activity in a large population of person's with- and without-HIV to assess the risk of functional limitations, frailty, and disability in this population. Over time, a better understanding of the factors that precede these conditions will lead to improved treatment and quality of life for those aging with HIV.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01AG048765-03
Application #
9104073
Study Section
Neuroscience of Aging Review Committee (NIA)
Program Officer
Eldadah, Basil A
Project Start
2014-08-15
Project End
2017-05-31
Budget Start
2016-06-15
Budget End
2017-05-31
Support Year
3
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Michos, Erin D; Mitchell, Christine M; Miller 3rd, Edgar R et al. (2018) Rationale and design of the Study To Understand Fall Reduction and Vitamin D in You (STURDY): A randomized clinical trial of Vitamin D supplement doses for the prevention of falls in older adults. Contemp Clin Trials 73:111-122
Gresham, Gillian; Dy, Sydney M; Zipunnikov, Vadim et al. (2018) Fatigability and endurance performance in cancer survivors: Analyses from the Baltimore Longitudinal Study of Aging. Cancer 124:1279-1287
Skarupski, Kimberly A; Gross, Alden; Schrack, Jennifer A et al. (2018) The Health of America's Aging Prison Population. Epidemiol Rev 40:157-165
Sun, Jing; Brown, Todd T; Samuels, David C et al. (2018) The Role of Mitochondrial DNA Variation in Age-Related Decline in Gait Speed Among Older Men Living With Human Immunodeficiency Virus. Clin Infect Dis 67:778-784
Nastasi, A J; McAdams-DeMarco, M A; Schrack, J et al. (2018) Pre-Kidney Transplant Lower Extremity Impairment and Post-Kidney Transplant Mortality. Am J Transplant 18:189-196
Godino, Job G; Appel, Lawrence J; Gross, Alden L et al. (2017) Diabetes, hyperglycemia, and the burden of functional disability among older adults in a community-based study. J Diabetes 9:76-84
Schrack, Jennifer A; Zipunnikov, Vadim; Simonsick, Eleanor M et al. (2016) Rising Energetic Cost of Walking Predicts Gait Speed Decline With Aging. J Gerontol A Biol Sci Med Sci 71:947-53
Erlandson, Kristine M; Zhang, Long; Lake, Jordan E et al. (2016) Changes in weight and weight distribution across the lifespan among HIV-infected and -uninfected men and women. Medicine (Baltimore) 95:e5399
Schrack, Jennifer A; Cooper, Rachel; Koster, Annemarie et al. (2016) Assessing Daily Physical Activity in Older Adults: Unraveling the Complexity of Monitors, Measures, and Methods. J Gerontol A Biol Sci Med Sci 71:1039-48
Ferrucci, Luigi; Cooper, Rachel; Shardell, Michelle et al. (2016) Age-Related Change in Mobility: Perspectives From Life Course Epidemiology and Geroscience. J Gerontol A Biol Sci Med Sci 71:1184-94

Showing the most recent 10 out of 14 publications